BioRestorative Therapies, Inc. (BRTX)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
BRTX Insider Trading Activity
BRTX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $10,229 | 2 | 67 |
Sells | $1,757 | 1 | 33 |
Related Transactions
| Silva Francisco | VP of Research and Development | 2 | $10,229 | 0 | $0 | $10,229 |
| Broadrick Dale | 10 percent owner | 0 | $0 | 1 | $1,757 | $-1,757 |
About BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase …
Insider Activity of BioRestorative Therapies, Inc.
Over the last 12 months, insiders at BioRestorative Therapies, Inc. have bought $10,229 and sold $1,757 worth of BioRestorative Therapies, Inc. stock.
On average, over the past 5 years, insiders at BioRestorative Therapies, Inc. have bought $484,929 and sold $7,679 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Silva Francisco (VP of Research and Development) — $10,229.
The last purchase of 6,600 shares for transaction amount of $8,250 was made by Silva Francisco (VP of Research and Development) on 2024‑04‑09.
List of Insider Buy and Sell Transactions, BioRestorative Therapies, Inc.
| 2024-10-28 | Sale | Broadrick Dale | 10 percent owner | 1,112 0.0157% | $1.58 | $1,757 | -1.27% | |
| 2024-04-09 | Silva Francisco | VP of Research and Development | 6,600 0.0952% | $1.25 | $8,250 | +23.44% | ||
| 2024-04-08 | Silva Francisco | VP of Research and Development | 1,708 0.0228% | $1.16 | $1,979 | +23.44% | ||
| 2024-02-09 | Broadrick Dale | 10 percent owner | 86,041 1.4895% | $1.32 | $113,574 | +11.85% | ||
| 2024-02-08 | Broadrick Dale | 10 percent owner | 157,585 2.6821% | $1.30 | $204,508 | +17.58% | ||
| 2024-02-08 | Broadrick Dale | 10 percent owner | 73,959 1.2124% | $1.25 | $92,449 | +17.58% | ||
| 2024-02-07 | Broadrick Dale | 10 percent owner | 36,374 0.6583% | $1.38 | $50,196 | +5.63% | ||
| 2023-12-01 | Sale | Broadrick Dale | 10 percent owner | 250 0.0053% | $1.88 | $469 | -15.68% | |
| 2023-11-27 | Sale | Broadrick Dale | 10 percent owner | 278 0.0059% | $1.89 | $525 | -17.37% | |
| 2023-09-15 | Broadrick Dale | 10 percent owner | 10,000 0.213% | $1.66 | $16,600 | -2.69% | ||
| 2023-09-15 | ALSTODT LANCE | President, CEO, COB | 2,200 0.048% | $1.70 | $3,740 | -2.69% | ||
| 2023-09-14 | Broadrick Dale | 10 percent owner | 10,000 0.2062% | $1.54 | $15,400 | +1.88% | ||
| 2023-09-13 | ALSTODT LANCE | President, CEO, COB | 800 0.0161% | $1.53 | $1,226 | +8.33% | ||
| 2023-09-07 | Broadrick Dale | 10 percent owner | 2,000 0.044% | $1.86 | $3,720 | -13.76% | ||
| 2023-09-06 | ALSTODT LANCE | President, CEO, COB | 2,887 0.0638% | $1.96 | $5,659 | -14.21% | ||
| 2023-08-31 | Silva Francisco | VP of Research and Development | 4,954 0.1071% | $2.22 | $10,998 | -25.45% | ||
| 2023-07-28 | Broadrick Dale | 10 percent owner | 500 0.016% | $2.89 | $1,445 | -39.82% | ||
| 2023-07-27 | Broadrick Dale | 10 percent owner | 1,000 0.031% | $2.80 | $2,800 | -39.22% | ||
| 2023-07-25 | ALSTODT LANCE | President, CEO, COB | 4,200 0.1134% | $2.44 | $10,248 | -29.22% | ||
| 2023-03-31 | Silva Francisco | VP of Research and Development | 747 0.0216% | $3.56 | $2,659 | -42.35% |
Insider Historical Profitability
| Broadrick Dale | 10 percent owner | 445933 6.4442% | $722,411.46 | 79 | 4 | <0.0001% |
| Silva Francisco | VP of Research and Development | 155759 2.2509% | $252,329.58 | 21 | 1 | <0.0001% |
| Westbury Trust | 10 percent owner | 3115000 45.015% | $5.05M | 1 | 0 | |
| Desmarais John M | 455000 6.5752% | $737,100.00 | 2 | 0 | ||
| ALSTODT LANCE | President, CEO, COB | 189505 2.7385% | $306,998.10 | 33 | 0 | <0.0001% |
Historical Insider Profitability vs. Competitors
$8,253,997 | 122 | -53.40% | $10.96M | |
BioRestorative Therapies, Inc. (BRTX) | $1,724,269 | 63 | -16.36% | $11.21M |
$1,159,104 | 40 | -21.75% | $8.25M | |
$383,884 | 32 | -25.10% | $12.83M | |
$95,303,339 | 30 | -13.78% | $11.33M |
BRTX Institutional Investors: Active Positions
| Increased Positions | 6 | +31.58% | 48,146 | +17.85% |
| Decreased Positions | 5 | -26.32% | 36,332 | -13.47% |
| New Positions | 3 | New | 21,542 | New |
| Sold Out Positions | 2 | Sold Out | 32,774 | Sold Out |
| Total Postitions | 20 | +5.26% | 281,572 | +4.38% |
BRTX Ownership Change vs Market
Institutional Investor Ownership
| Geode Capital Management, Llc | $83.00 | 0.78% | 54,722 | -984 | -1.77% | 2024-12-31 |
| Stonex Group Inc. | $76.00 | 0.72% | 50,100 | 0 | 0% | 2024-12-31 |
| Wealth Alliance | $61.00 | 0.57% | 40,000 | 0 | 0% | 2024-12-31 |
| Morgan Stanley | $42.00 | 0.39% | 27,500 | +10,000 | +57.14% | 2024-12-31 |
| Citadel Advisors Llc | $33.00 | 0.31% | 21,481 | +21,481 | New | 2024-12-31 |
| Vanguard Group Inc | $31.00 | 0.29% | 20,472 | 0 | 0% | 2024-12-31 |
| State Street Corp | $31.00 | 0.29% | 20,459 | 0 | 0% | 2024-12-31 |
| Us Financial Advisors, Llc | $26.00 | 0.25% | 17,142 | 0 | 0% | 2024-12-31 |
| Ubs Group Ag | $25.00 | 0.23% | 16,297 | +15,604 | +2,251.66% | 2024-12-31 |
| Newman Dignan & Sheerar, Inc. | $18.00 | 0.17% | 11,522 | +1,000 | +9.5% | 2024-12-31 |